Comorbidities and medications of patients with chronic hepatitis C under specialist care in the UK.
Designing services with the capacity and expertise to meet the needs of the chronic hepatitis C (CHC) population in the era of direct acting antivirals (DAAs), and widening access to such treatments, requires detailed understanding of the characteristics and healthcare needs of the existing patient...
Main Authors: | , , |
---|---|
Format: | Journal article |
Language: | English |
Published: |
Wiley
2017
|